Rank | Gene Set | Z-score |
---|---|---|
1 | cardiac myofibril assembly (GO:0055003) | 8.68565157 |
2 | sarcomere organization (GO:0045214) | 8.25905411 |
3 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 8.15733167 |
4 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 7.65548969 |
5 | tricarboxylic acid cycle (GO:0006099) | 7.36617793 |
6 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 7.26052869 |
7 | myofibril assembly (GO:0030239) | 7.18634605 |
8 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.93862047 |
9 | regulation of relaxation of muscle (GO:1901077) | 6.77769806 |
10 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.76467028 |
11 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 6.75297265 |
12 | cardiac muscle contraction (GO:0060048) | 6.66294011 |
13 | cardiac muscle cell development (GO:0055013) | 6.28892233 |
14 | regulation of sarcomere organization (GO:0060297) | 6.26603787 |
15 | regulation of actin filament-based movement (GO:1903115) | 6.21232549 |
16 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 6.08753515 |
17 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.93119965 |
18 | cardiac cell development (GO:0055006) | 5.89529779 |
19 | cardiac muscle hypertrophy (GO:0003300) | 5.84062855 |
20 | ventricular cardiac muscle cell action potential (GO:0086005) | 5.83551312 |
21 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.60658387 |
22 | cardiac muscle tissue morphogenesis (GO:0055008) | 5.52901266 |
23 | striated muscle hypertrophy (GO:0014897) | 5.50622056 |
24 | heart trabecula formation (GO:0060347) | 5.46484134 |
25 | muscle filament sliding (GO:0030049) | 5.45330434 |
26 | actin-myosin filament sliding (GO:0033275) | 5.45330434 |
27 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 5.42393105 |
28 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.42240098 |
29 | regulation of cell communication by electrical coupling (GO:0010649) | 5.38104169 |
30 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 5.33933942 |
31 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.33404912 |
32 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.32195526 |
33 | ATP synthesis coupled proton transport (GO:0015986) | 5.32195526 |
34 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 5.31370766 |
35 | cardiac chamber formation (GO:0003207) | 5.26677659 |
36 | actomyosin structure organization (GO:0031032) | 5.21012895 |
37 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 5.20675782 |
38 | respiratory electron transport chain (GO:0022904) | 5.16723643 |
39 | cell communication involved in cardiac conduction (GO:0086065) | 5.15108433 |
40 | carnitine shuttle (GO:0006853) | 5.12433856 |
41 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.07235259 |
42 | electron transport chain (GO:0022900) | 5.01371746 |
43 | adult heart development (GO:0007512) | 4.99775514 |
44 | regulation of cofactor metabolic process (GO:0051193) | 4.97679735 |
45 | regulation of coenzyme metabolic process (GO:0051196) | 4.97679735 |
46 | regulation of striated muscle contraction (GO:0006942) | 4.96272363 |
47 | regulation of the force of heart contraction (GO:0002026) | 4.93266170 |
48 | muscle tissue morphogenesis (GO:0060415) | 4.89813963 |
49 | heart contraction (GO:0060047) | 4.88397764 |
50 | heart process (GO:0003015) | 4.88397764 |
51 | muscle hypertrophy (GO:0014896) | 4.88148044 |
52 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.85884272 |
53 | relaxation of cardiac muscle (GO:0055119) | 4.80123861 |
54 | regulation of cardiac muscle cell contraction (GO:0086004) | 4.78007458 |
55 | oxidative phosphorylation (GO:0006119) | 4.76942676 |
56 | regulation of membrane repolarization (GO:0060306) | 4.75993369 |
57 | adrenergic receptor signaling pathway (GO:0071875) | 4.72816898 |
58 | cardiac ventricle formation (GO:0003211) | 4.71043425 |
59 | striated muscle contraction (GO:0006941) | 4.69550678 |
60 | cell communication by electrical coupling (GO:0010644) | 4.59149572 |
61 | fatty acid transmembrane transport (GO:1902001) | 4.59125107 |
62 | plasma membrane repair (GO:0001778) | 4.58592455 |
63 | actin-mediated cell contraction (GO:0070252) | 4.56167798 |
64 | regulation of skeletal muscle contraction (GO:0014819) | 4.52395955 |
65 | regulation of cardiac muscle contraction (GO:0055117) | 4.52376045 |
66 | response to caffeine (GO:0031000) | 4.39066234 |
67 | cellular response to epinephrine stimulus (GO:0071872) | 4.27772502 |
68 | ventricular cardiac muscle cell development (GO:0055015) | 4.23632349 |
69 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 4.15200345 |
70 | cardiac muscle cell action potential (GO:0086001) | 4.12993445 |
71 | response to epinephrine (GO:0071871) | 4.12265992 |
72 | regulation of heart rate (GO:0002027) | 4.11155772 |
73 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 4.10882485 |
74 | 2-oxoglutarate metabolic process (GO:0006103) | 4.07717890 |
75 | cardiac muscle adaptation (GO:0014887) | 4.07597860 |
76 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 4.07597860 |
77 | muscle hypertrophy in response to stress (GO:0003299) | 4.07597860 |
78 | regulation of sulfur metabolic process (GO:0042762) | 4.04016348 |
79 | cardiac conduction (GO:0061337) | 3.97721096 |
80 | relaxation of muscle (GO:0090075) | 3.95875393 |
81 | NADH metabolic process (GO:0006734) | 3.95443950 |
82 | positive regulation of action potential (GO:0045760) | 3.95319719 |
83 | negative regulation of potassium ion transport (GO:0043267) | 3.94405915 |
84 | positive regulation of ATP catabolic process (GO:1903291) | 3.91082940 |
85 | positive regulation of ATPase activity (GO:0032781) | 3.91082940 |
86 | carnitine transmembrane transport (GO:1902603) | 3.80074312 |
87 | creatine metabolic process (GO:0006600) | 3.79731626 |
88 | detection of calcium ion (GO:0005513) | 3.76491714 |
89 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.75379803 |
90 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.74581276 |
91 | succinate metabolic process (GO:0006105) | 3.73553879 |
92 | cardiac muscle tissue development (GO:0048738) | 3.71417773 |
93 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.69927359 |
94 | response to inactivity (GO:0014854) | 3.69328433 |
95 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.67790500 |
96 | regulation of heart contraction (GO:0008016) | 3.67530940 |
97 | regulation of ATPase activity (GO:0043462) | 3.67321237 |
98 | regulation of ATP catabolic process (GO:1903289) | 3.67321237 |
99 | regulation of muscle contraction (GO:0006937) | 3.66765115 |
100 | atrial septum morphogenesis (GO:0060413) | 3.66683768 |
101 | negative regulation of heart rate (GO:0010459) | 3.64015630 |
102 | regulation of sequestering of triglyceride (GO:0010889) | 3.62539681 |
103 | fatty acid beta-oxidation (GO:0006635) | 3.61916780 |
104 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.60824008 |
105 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.52321413 |
106 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.52321413 |
107 | positive regulation of heart contraction (GO:0045823) | 3.51988853 |
108 | ATP biosynthetic process (GO:0006754) | 3.49786985 |
109 | positive regulation of heart rate (GO:0010460) | 3.49523318 |
110 | regulation of cardioblast differentiation (GO:0051890) | 3.46329076 |
111 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 3.45972695 |
112 | amino-acid betaine transport (GO:0015838) | 3.45314681 |
113 | carnitine transport (GO:0015879) | 3.45314681 |
114 | trabecula formation (GO:0060343) | 3.43351632 |
115 | actin filament-based movement (GO:0030048) | 3.40016990 |
116 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.38129601 |
117 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.38129601 |
118 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.35918730 |
119 | aspartate family amino acid catabolic process (GO:0009068) | 3.35605739 |
120 | positive regulation of sodium ion transport (GO:0010765) | 3.35269193 |
121 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 3.34627051 |
122 | muscle contraction (GO:0006936) | 3.34376041 |
123 | regulation of muscle system process (GO:0090257) | 3.31685619 |
124 | striated muscle cell development (GO:0055002) | 3.31291354 |
125 | regulation of cation channel activity (GO:2001257) | 3.29725452 |
126 | relaxation of smooth muscle (GO:0044557) | 3.27952473 |
127 | striated muscle adaptation (GO:0014888) | 3.24691552 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 7.72577621 |
2 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 5.70837471 |
3 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 5.38265152 |
4 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.50033382 |
5 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 4.22628454 |
6 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 4.22628454 |
7 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.90854153 |
8 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 3.39278450 |
9 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 3.21898974 |
10 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.97494232 |
11 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.83400339 |
12 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.69884124 |
13 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.63692197 |
14 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.44053107 |
15 | GATA1_22025678_ChIP-Seq_K562_Human | 2.29654229 |
16 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.22751248 |
17 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.09011347 |
18 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 2.04233138 |
19 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 2.01436856 |
20 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.00655599 |
21 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.94371332 |
22 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.92882811 |
23 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.91947479 |
24 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.90021644 |
25 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.82132620 |
26 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.79352597 |
27 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.75992679 |
28 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.74919372 |
29 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.74325957 |
30 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.72330511 |
31 | * VDR_22108803_ChIP-Seq_LS180_Human | 1.69241535 |
32 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.64864652 |
33 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.64787287 |
34 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.63989945 |
35 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.57409958 |
36 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.56358791 |
37 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.54061277 |
38 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.51844448 |
39 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.50295821 |
40 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.45538818 |
41 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.44536518 |
42 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.43865810 |
43 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.42494614 |
44 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.40385976 |
45 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.40140821 |
46 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.38651233 |
47 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.37037687 |
48 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.33885682 |
49 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.33885682 |
50 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.33557898 |
51 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.31360427 |
52 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.29795029 |
53 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.29733508 |
54 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.29459202 |
55 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.29031549 |
56 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.28544099 |
57 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.26792709 |
58 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.25044132 |
59 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.24790632 |
60 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.23447977 |
61 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.22337055 |
62 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.22330567 |
63 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.21970231 |
64 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.21937203 |
65 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.21450815 |
66 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.20468978 |
67 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.19395406 |
68 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.18527120 |
69 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.17892738 |
70 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.16985514 |
71 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.15958878 |
72 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.14798733 |
73 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.13443660 |
74 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.11972504 |
75 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.11782888 |
76 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.11322188 |
77 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.10955982 |
78 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.07936609 |
79 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.07462985 |
80 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.07256444 |
81 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.06812371 |
82 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.06654254 |
83 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.06440697 |
84 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.06259513 |
85 | CJUN_26792858_Chip-Seq_BT549_Human | 1.06247505 |
86 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.05851441 |
87 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.05062324 |
88 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.05026028 |
89 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.03542222 |
90 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.02469092 |
91 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.02451113 |
92 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.01705950 |
93 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.01435763 |
94 | * TBL1_22424771_ChIP-Seq_293T_Human | 1.00435104 |
95 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.00335801 |
96 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.99189630 |
97 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98960208 |
98 | * AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.98800341 |
99 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98673282 |
100 | P300_19829295_ChIP-Seq_ESCs_Human | 0.98553772 |
101 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.97705618 |
102 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.97095574 |
103 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.96636775 |
104 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.96164906 |
105 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.96164906 |
106 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.95309902 |
107 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.94695771 |
108 | STAT3_18555785_ChIP-Seq_MESCs_Mouse | 0.94634003 |
109 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.94010715 |
110 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.93961963 |
111 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.93546277 |
112 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.93151932 |
113 | GATA1_19941826_ChIP-Seq_K562_Human | 0.92665508 |
114 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.91396564 |
115 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.88424639 |
116 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.88313592 |
117 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.86853737 |
118 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.86364480 |
119 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.86274002 |
120 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.82784890 |
121 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.82473723 |
122 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.82355345 |
123 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.82213147 |
124 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.78385772 |
125 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.78004522 |
126 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.77951749 |
127 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.77315717 |
128 | ATF3_27146783_Chip-Seq_COLON_Human | 0.76978307 |
129 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.75724065 |
130 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.75352714 |
131 | GATA2_19941826_ChIP-Seq_K562_Human | 0.75197387 |
132 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.75159671 |
133 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.74929664 |
134 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.74731341 |
135 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.73767120 |
136 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.72191822 |
137 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.72160891 |
138 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.70650321 |
139 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.70525499 |
140 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.69381516 |
141 | TP53_16413492_ChIP-PET_HCT116_Human | 0.69248751 |
142 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.69054953 |
143 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.68982862 |
144 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.68760588 |
145 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.67767482 |
146 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.67714779 |
147 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.67407950 |
148 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.65984246 |
149 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.65929595 |
150 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.64808427 |
151 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.64686555 |
152 | * PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.64237541 |
153 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.64106788 |
154 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.63510542 |
155 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.63476172 |
156 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.63359954 |
157 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.63041914 |
158 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.62420107 |
159 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.60225052 |
160 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.60031542 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004084_abnormal_cardiac_muscle | 6.25686297 |
2 | MP0002837_dystrophic_cardiac_calcinosis | 6.19830722 |
3 | MP0004215_abnormal_myocardial_fiber | 5.27757327 |
4 | MP0003646_muscle_fatigue | 5.15561021 |
5 | MP0000751_myopathy | 4.82509191 |
6 | MP0005330_cardiomyopathy | 4.28441269 |
7 | MP0004036_abnormal_muscle_relaxation | 4.22890094 |
8 | MP0000749_muscle_degeneration | 3.54318221 |
9 | MP0008775_abnormal_heart_ventricle | 3.46890897 |
10 | MP0002972_abnormal_cardiac_muscle | 3.40604670 |
11 | MP0004484_altered_response_of | 3.10452790 |
12 | MP0003137_abnormal_impulse_conducting | 3.08536067 |
13 | MP0004087_abnormal_muscle_fiber | 3.01074887 |
14 | MP0001544_abnormal_cardiovascular_syste | 2.84466722 |
15 | MP0005385_cardiovascular_system_phenoty | 2.84466722 |
16 | MP0010630_abnormal_cardiac_muscle | 2.79375536 |
17 | MP0004130_abnormal_muscle_cell | 2.77411163 |
18 | MP0005620_abnormal_muscle_contractility | 2.67250210 |
19 | MP0000750_abnormal_muscle_regeneration | 2.54979692 |
20 | MP0006138_congestive_heart_failure | 2.48626917 |
21 | MP0003828_pulmonary_edema | 2.47257361 |
22 | MP0004085_abnormal_heartbeat | 2.34756936 |
23 | MP0004510_myositis | 2.32380269 |
24 | MP0002106_abnormal_muscle_physiology | 2.29770390 |
25 | MP0003221_abnormal_cardiomyocyte_apopto | 2.20884883 |
26 | MP0002269_muscular_atrophy | 2.05808692 |
27 | MP0006036_abnormal_mitochondrial_physio | 2.00356096 |
28 | MP0002127_abnormal_cardiovascular_syste | 1.87534318 |
29 | MP0005369_muscle_phenotype | 1.81964300 |
30 | MP0004145_abnormal_muscle_electrophysio | 1.71859492 |
31 | MP0003950_abnormal_plasma_membrane | 1.68326713 |
32 | MP0000759_abnormal_skeletal_muscle | 1.66470191 |
33 | MP0000747_muscle_weakness | 1.64616866 |
34 | MP0004233_abnormal_muscle_weight | 1.52387857 |
35 | MP0002332_abnormal_exercise_endurance | 1.50207031 |
36 | MP0003567_abnormal_fetal_cardiomyocyte | 1.47234803 |
37 | MP0005165_increased_susceptibility_to | 1.39537433 |
38 | MP0000343_altered_response_to | 1.30111956 |
39 | MP0005666_abnormal_adipose_tissue | 1.27570107 |
40 | MP0006035_abnormal_mitochondrial_morpho | 1.23381575 |
41 | MP0000266_abnormal_heart_morphology | 1.22505990 |
42 | MP0010368_abnormal_lymphatic_system | 1.13111554 |
43 | MP0003279_aneurysm | 1.01803923 |
44 | MP0005670_abnormal_white_adipose | 1.00292694 |
45 | MP0000230_abnormal_systemic_arterial | 0.90989877 |
46 | MP0002234_abnormal_pharynx_morphology | 0.89456033 |
47 | MP0008004_abnormal_stomach_pH | 0.88057791 |
48 | MP0001984_abnormal_olfaction | 0.87053955 |
49 | MP0004043_abnormal_pH_regulation | 0.84982441 |
50 | MP0005266_abnormal_metabolism | 0.84655167 |
51 | MP0005375_adipose_tissue_phenotype | 0.83250016 |
52 | MP0003566_abnormal_cell_adhesion | 0.82351215 |
53 | MP0002128_abnormal_blood_circulation | 0.81693972 |
54 | MP0005623_abnormal_meninges_morphology | 0.79826441 |
55 | MP0004185_abnormal_adipocyte_glucose | 0.79295894 |
56 | MP0001661_extended_life_span | 0.72815203 |
57 | MP0009745_abnormal_behavioral_response | 0.67412070 |
58 | MP0002108_abnormal_muscle_morphology | 0.66517095 |
59 | MP0001879_abnormal_lymphatic_vessel | 0.65727929 |
60 | MP0008569_lethality_at_weaning | 0.64765447 |
61 | MP0005451_abnormal_body_composition | 0.61120932 |
62 | MP0004147_increased_porphyrin_level | 0.60864095 |
63 | MP0002735_abnormal_chemical_nociception | 0.60438040 |
64 | MP0003880_abnormal_central_pattern | 0.58994098 |
65 | MP0003806_abnormal_nucleotide_metabolis | 0.58136664 |
66 | MP0004272_abnormal_basement_membrane | 0.57880587 |
67 | MP0009384_cardiac_valve_regurgitation | 0.54992158 |
68 | MP0002272_abnormal_nervous_system | 0.54981198 |
69 | MP0000003_abnormal_adipose_tissue | 0.54800645 |
70 | MP0000767_abnormal_smooth_muscle | 0.54338628 |
71 | MP0000013_abnormal_adipose_tissue | 0.53951241 |
72 | MP0002909_abnormal_adrenal_gland | 0.53592251 |
73 | MP0002078_abnormal_glucose_homeostasis | 0.49373493 |
74 | MP0005503_abnormal_tendon_morphology | 0.48846409 |
75 | MP0005319_abnormal_enzyme/_coenzyme | 0.48715273 |
76 | MP0005187_abnormal_penis_morphology | 0.48051782 |
77 | MP0003787_abnormal_imprinting | 0.45985750 |
78 | MP0002971_abnormal_brown_adipose | 0.45310110 |
79 | MP0006072_abnormal_retinal_apoptosis | 0.45178291 |
80 | MP0001486_abnormal_startle_reflex | 0.44781716 |
81 | MP0008438_abnormal_cutaneous_collagen | 0.43868101 |
82 | MP0002925_abnormal_cardiovascular_devel | 0.43721207 |
83 | MP0003705_abnormal_hypodermis_morpholog | 0.42217522 |
84 | MP0003984_embryonic_growth_retardation | 0.41872465 |
85 | MP0005535_abnormal_body_temperature | 0.41595125 |
86 | MP0002088_abnormal_embryonic_growth/wei | 0.41121937 |
87 | MP0002064_seizures | 0.41071764 |
88 | MP0003195_calcinosis | 0.41000627 |
89 | MP0002638_abnormal_pupillary_reflex | 0.40455147 |
90 | MP0005085_abnormal_gallbladder_physiolo | 0.39376482 |
91 | MP0005386_behavior/neurological_phenoty | 0.38634354 |
92 | MP0004924_abnormal_behavior | 0.38634354 |
93 | MP0004859_abnormal_synaptic_plasticity | 0.38005108 |
94 | MP0001614_abnormal_blood_vessel | 0.36890227 |
95 | MP0002822_catalepsy | 0.36454699 |
96 | MP0003635_abnormal_synaptic_transmissio | 0.35961414 |
97 | MP0003136_yellow_coat_color | 0.35681566 |
98 | MP0005275_abnormal_skin_tensile | 0.35323691 |
99 | MP0002063_abnormal_learning/memory/cond | 0.35302646 |
100 | MP0000733_abnormal_muscle_development | 0.35103259 |
101 | MP0006276_abnormal_autonomic_nervous | 0.34403323 |
102 | MP0002877_abnormal_melanocyte_morpholog | 0.34000163 |
103 | MP0001784_abnormal_fluid_regulation | 0.33884229 |
104 | MP0005248_abnormal_Harderian_gland | 0.33522839 |
105 | MP0005595_abnormal_vascular_smooth | 0.32168819 |
106 | MP0005332_abnormal_amino_acid | 0.32165936 |
107 | MP0005423_abnormal_somatic_nervous | 0.32113338 |
108 | MP0001440_abnormal_grooming_behavior | 0.31935850 |
109 | MP0002572_abnormal_emotion/affect_behav | 0.31739890 |
110 | MP0001727_abnormal_embryo_implantation | 0.30841248 |
111 | MP0001970_abnormal_pain_threshold | 0.30265902 |
112 | MP0008961_abnormal_basal_metabolism | 0.29622124 |
113 | MP0002295_abnormal_pulmonary_circulatio | 0.29005071 |
114 | MP0002090_abnormal_vision | 0.28274059 |
115 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.27705067 |
116 | MP0001986_abnormal_taste_sensitivity | 0.26996390 |
117 | MP0003948_abnormal_gas_homeostasis | 0.26411311 |
118 | MP0002118_abnormal_lipid_homeostasis | 0.26319512 |
119 | MP0009046_muscle_twitch | 0.25671798 |
120 | MP0005167_abnormal_blood-brain_barrier | 0.25597226 |
121 | MP0005388_respiratory_system_phenotype | 0.25113592 |
122 | MP0002133_abnormal_respiratory_system | 0.25113592 |
123 | MP0005253_abnormal_eye_physiology | 0.24638734 |
124 | MP0002102_abnormal_ear_morphology | 0.24173029 |
125 | MP0001299_abnormal_eye_distance/ | 0.23979057 |
126 | MP0000249_abnormal_blood_vessel | 0.23076485 |
127 | MP0001529_abnormal_vocalization | 0.22173208 |
128 | MP0009780_abnormal_chondrocyte_physiolo | 0.21752796 |
129 | MP0003045_fibrosis | 0.21652802 |
130 | MP0005334_abnormal_fat_pad | 0.19381398 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Sudden death (HP:0001699) | 8.11714032 |
2 | Ventricular tachycardia (HP:0004756) | 7.14149848 |
3 | Atrial fibrillation (HP:0005110) | 6.50777874 |
4 | Primary atrial arrhythmia (HP:0001692) | 6.08086128 |
5 | Supraventricular tachycardia (HP:0004755) | 5.87898473 |
6 | Supraventricular arrhythmia (HP:0005115) | 5.74769283 |
7 | Calf muscle hypertrophy (HP:0008981) | 5.53500454 |
8 | Syncope (HP:0001279) | 5.47455852 |
9 | Right ventricular cardiomyopathy (HP:0011663) | 5.37099707 |
10 | Lipoatrophy (HP:0100578) | 5.32578495 |
11 | Abnormality of the calf musculature (HP:0001430) | 4.94754000 |
12 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.94126310 |
13 | Exercise-induced muscle cramps (HP:0003710) | 4.93919439 |
14 | Bundle branch block (HP:0011710) | 4.92963039 |
15 | Palpitations (HP:0001962) | 4.84807995 |
16 | Myoglobinuria (HP:0002913) | 4.77889222 |
17 | Exercise-induced myalgia (HP:0003738) | 4.77024538 |
18 | Muscle fiber splitting (HP:0003555) | 4.43647408 |
19 | Dilated cardiomyopathy (HP:0001644) | 4.43443478 |
20 | Prolonged QT interval (HP:0001657) | 4.39907911 |
21 | Ventricular arrhythmia (HP:0004308) | 4.33067425 |
22 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.20544950 |
23 | Subaortic stenosis (HP:0001682) | 4.20544950 |
24 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.19665979 |
25 | Acute necrotizing encephalopathy (HP:0006965) | 4.17878139 |
26 | Hyporeflexia of lower limbs (HP:0002600) | 4.16180343 |
27 | Heart block (HP:0012722) | 3.99465719 |
28 | EMG: neuropathic changes (HP:0003445) | 3.89091854 |
29 | Asymmetric septal hypertrophy (HP:0001670) | 3.88446608 |
30 | Hepatic necrosis (HP:0002605) | 3.78027129 |
31 | Abnormal atrioventricular conduction (HP:0005150) | 3.77533693 |
32 | Ventricular fibrillation (HP:0001663) | 3.67162956 |
33 | Atrioventricular block (HP:0001678) | 3.66036890 |
34 | Acute encephalopathy (HP:0006846) | 3.59318774 |
35 | Progressive macrocephaly (HP:0004481) | 3.53197962 |
36 | Rhabdomyolysis (HP:0003201) | 3.49712553 |
37 | EMG: myopathic abnormalities (HP:0003458) | 3.45042170 |
38 | Hypoglycemic coma (HP:0001325) | 3.44859799 |
39 | Hepatocellular necrosis (HP:0001404) | 3.21865131 |
40 | Ketoacidosis (HP:0001993) | 3.21740394 |
41 | Bradycardia (HP:0001662) | 3.21173827 |
42 | Cerebral edema (HP:0002181) | 3.20717224 |
43 | Mitochondrial inheritance (HP:0001427) | 3.17574961 |
44 | Abnormal EKG (HP:0003115) | 3.13328665 |
45 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.09803413 |
46 | Left ventricular hypertrophy (HP:0001712) | 3.04937819 |
47 | Increased CSF lactate (HP:0002490) | 3.03644091 |
48 | Congenital malformation of the right heart (HP:0011723) | 3.00881998 |
49 | Double outlet right ventricle (HP:0001719) | 3.00881998 |
50 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.98123877 |
51 | Dicarboxylic aciduria (HP:0003215) | 2.98123877 |
52 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.93799732 |
53 | Abnormality of alanine metabolism (HP:0010916) | 2.93799732 |
54 | Hyperalaninemia (HP:0003348) | 2.93799732 |
55 | Conjunctival hamartoma (HP:0100780) | 2.91007232 |
56 | Rimmed vacuoles (HP:0003805) | 2.84928060 |
57 | Increased connective tissue (HP:0009025) | 2.82953628 |
58 | Ragged-red muscle fibers (HP:0003200) | 2.82229025 |
59 | Hypoplastic left heart (HP:0004383) | 2.82184837 |
60 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.80663401 |
61 | Palmoplantar keratoderma (HP:0000982) | 2.69656608 |
62 | Pheochromocytoma (HP:0002666) | 2.68321029 |
63 | Type 1 muscle fiber predominance (HP:0003803) | 2.67989063 |
64 | Lactic acidosis (HP:0003128) | 2.65897646 |
65 | Myotonia (HP:0002486) | 2.61548005 |
66 | Respiratory failure (HP:0002878) | 2.61046541 |
67 | Exercise intolerance (HP:0003546) | 2.56266543 |
68 | Difficulty running (HP:0009046) | 2.55727326 |
69 | Increased muscle lipid content (HP:0009058) | 2.54191703 |
70 | Neoplasm of the adrenal gland (HP:0100631) | 2.51924779 |
71 | Neuroendocrine neoplasm (HP:0100634) | 2.41942549 |
72 | Distal lower limb muscle weakness (HP:0009053) | 2.41405972 |
73 | Myokymia (HP:0002411) | 2.40247093 |
74 | Abnormality of glycolysis (HP:0004366) | 2.37064171 |
75 | Increased serum pyruvate (HP:0003542) | 2.37064171 |
76 | Sudden cardiac death (HP:0001645) | 2.35267830 |
77 | Increased intramyocellular lipid droplets (HP:0012240) | 2.31967573 |
78 | Generalized muscle weakness (HP:0003324) | 2.26638035 |
79 | Ketosis (HP:0001946) | 2.26167642 |
80 | Generalized aminoaciduria (HP:0002909) | 2.25467879 |
81 | Difficulty climbing stairs (HP:0003551) | 2.21568364 |
82 | Neoplasm of head and neck (HP:0012288) | 2.21131718 |
83 | Esophageal neoplasm (HP:0100751) | 2.21131718 |
84 | Hypoplastic heart (HP:0001961) | 2.21051649 |
85 | Hamartoma of the eye (HP:0010568) | 2.15600885 |
86 | Abnormality of the tricuspid valve (HP:0001702) | 2.12637563 |
87 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.12611549 |
88 | Steppage gait (HP:0003376) | 2.11606379 |
89 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.10385461 |
90 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.10385461 |
91 | Foot dorsiflexor weakness (HP:0009027) | 2.07975286 |
92 | Lipid accumulation in hepatocytes (HP:0006561) | 2.06999118 |
93 | Areflexia of lower limbs (HP:0002522) | 2.06124832 |
94 | Congestive heart failure (HP:0001635) | 2.03858467 |
95 | Limb hypertonia (HP:0002509) | 1.99642891 |
96 | Muscle stiffness (HP:0003552) | 1.99088484 |
97 | Nausea (HP:0002018) | 1.96637806 |
98 | Hyperammonemia (HP:0001987) | 1.93131918 |
99 | Resting tremor (HP:0002322) | 1.92992663 |
100 | Limb-girdle muscle atrophy (HP:0003797) | 1.92684061 |
101 | Athetosis (HP:0002305) | 1.90767154 |
102 | Hypoplastic ischia (HP:0003175) | 1.89250688 |
103 | Hyperglycemia (HP:0003074) | 1.87324780 |
104 | Optic disc pallor (HP:0000543) | 1.86130860 |
105 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.84719510 |
106 | Central scotoma (HP:0000603) | 1.84079517 |
107 | Increased variability in muscle fiber diameter (HP:0003557) | 1.81749453 |
108 | Multiple enchondromatosis (HP:0005701) | 1.80777791 |
109 | Lymphangioma (HP:0100764) | 1.79652702 |
110 | Large for gestational age (HP:0001520) | 1.78749563 |
111 | Toxemia of pregnancy (HP:0100603) | 1.78367156 |
112 | Increased serum lactate (HP:0002151) | 1.78264999 |
113 | Neck muscle weakness (HP:0000467) | 1.76982272 |
114 | Testicular atrophy (HP:0000029) | 1.76320306 |
115 | Tinnitus (HP:0000360) | 1.75861596 |
116 | Lethargy (HP:0001254) | 1.75177792 |
117 | Abnormality of the foot musculature (HP:0001436) | 1.73389423 |
118 | Muscular dystrophy (HP:0003560) | 1.66538793 |
119 | Abnormality of the endocardium (HP:0004306) | 1.65646677 |
120 | Skin nodule (HP:0200036) | 1.64829982 |
121 | Scapular winging (HP:0003691) | 1.61870186 |
122 | Late onset (HP:0003584) | 1.58285956 |
123 | Dysmetric saccades (HP:0000641) | 1.56936058 |
124 | Prenatal maternal abnormality (HP:0002686) | 1.52614751 |
125 | Frequent falls (HP:0002359) | 1.50244908 |
126 | Patent foramen ovale (HP:0001655) | 1.49467746 |
127 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.48016882 |
128 | Childhood onset (HP:0011463) | 1.47724016 |
129 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.44338526 |
130 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.39796353 |
131 | Periauricular skin pits (HP:0100277) | 1.35167973 |
132 | Preauricular pit (HP:0004467) | 1.35167973 |
133 | Muscle fiber inclusion bodies (HP:0100299) | 1.33737626 |
134 | Pulmonary artery stenosis (HP:0004415) | 1.32292047 |
135 | Anomalous pulmonary venous return (HP:0010772) | 1.32112742 |
136 | Transposition of the great arteries (HP:0001669) | 1.31509531 |
137 | Abnormal connection of the cardiac segments (HP:0011545) | 1.31509531 |
138 | Abnormal ventriculo-arterial connection (HP:0011563) | 1.31509531 |
139 | Maternal diabetes (HP:0009800) | 1.31251625 |
140 | Skin pits (HP:0100276) | 1.30372233 |
141 | Proximal amyotrophy (HP:0007126) | 1.30095932 |
142 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.27327323 |
143 | Distal lower limb amyotrophy (HP:0008944) | 1.26959472 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TTN | 5.34071225 |
2 | LMTK2 | 4.14517038 |
3 | PDK4 | 4.13623097 |
4 | PDK3 | 4.13623097 |
5 | MYLK | 3.93398069 |
6 | OBSCN | 3.75382864 |
7 | PKN2 | 3.73111412 |
8 | PHKG2 | 3.51111102 |
9 | PHKG1 | 3.51111102 |
10 | DMPK | 2.86072257 |
11 | STK24 | 2.67835168 |
12 | TRIB3 | 2.54997868 |
13 | PDK2 | 2.54802809 |
14 | BCKDK | 2.39208740 |
15 | GRK7 | 2.24008037 |
16 | NEK1 | 2.15226958 |
17 | TIE1 | 2.11137863 |
18 | PIK3CA | 2.10853646 |
19 | MUSK | 2.09012742 |
20 | PINK1 | 2.02878529 |
21 | MARK1 | 2.02603106 |
22 | CAMK2D | 1.53494803 |
23 | PAK3 | 1.49449011 |
24 | NME2 | 1.38230690 |
25 | ILK | 1.34605740 |
26 | PRKD1 | 1.33176070 |
27 | WNK4 | 1.25435716 |
28 | INSRR | 1.22951560 |
29 | STK38L | 1.22557403 |
30 | FLT3 | 1.20722782 |
31 | TRPM7 | 1.09352922 |
32 | ZAK | 1.09239715 |
33 | CDC42BPA | 1.09173301 |
34 | STK4 | 1.06210329 |
35 | CAMK4 | 1.03229618 |
36 | ROCK1 | 0.95502417 |
37 | MAP3K6 | 0.92251563 |
38 | MAP3K7 | 0.90824410 |
39 | EPHA4 | 0.86674767 |
40 | PRKAA2 | 0.85073907 |
41 | PRKAA1 | 0.85043194 |
42 | MAPK12 | 0.84816422 |
43 | DAPK3 | 0.82143166 |
44 | CAMK2A | 0.78171372 |
45 | STK38 | 0.76647016 |
46 | STK39 | 0.76480171 |
47 | MAP3K5 | 0.75867340 |
48 | EPHA3 | 0.75473053 |
49 | CAMK1 | 0.71255481 |
50 | WNK1 | 0.70581502 |
51 | NEK9 | 0.70062304 |
52 | MAP4K2 | 0.67017071 |
53 | PDGFRA | 0.65748827 |
54 | AKT3 | 0.65489049 |
55 | KDR | 0.65437612 |
56 | RIPK1 | 0.63846573 |
57 | PKN1 | 0.63714894 |
58 | MAPKAPK3 | 0.63586417 |
59 | ROCK2 | 0.53185223 |
60 | NTRK2 | 0.51378172 |
61 | WNK3 | 0.51038510 |
62 | MAP3K3 | 0.50638673 |
63 | PTK2B | 0.49886366 |
64 | MAP3K12 | 0.49853896 |
65 | NTRK3 | 0.49567158 |
66 | FRK | 0.49205503 |
67 | PLK2 | 0.48901457 |
68 | PRKCE | 0.48674094 |
69 | ITK | 0.48235556 |
70 | CAMK2G | 0.47109926 |
71 | PRKACB | 0.45940884 |
72 | MAPK13 | 0.44429837 |
73 | PRKACG | 0.44221428 |
74 | TGFBR2 | 0.43067034 |
75 | PRKACA | 0.42873109 |
76 | MAP2K3 | 0.42862560 |
77 | RPS6KC1 | 0.42446276 |
78 | RPS6KL1 | 0.42446276 |
79 | MAPK4 | 0.41596244 |
80 | LIMK1 | 0.41481853 |
81 | PDK1 | 0.40923394 |
82 | CDK5 | 0.40700594 |
83 | PDPK1 | 0.39490592 |
84 | TNIK | 0.38385821 |
85 | RPS6KA6 | 0.33987927 |
86 | STK11 | 0.33290697 |
87 | MAP2K1 | 0.32772278 |
88 | RET | 0.32032036 |
89 | LATS2 | 0.32010054 |
90 | SGK2 | 0.30701658 |
91 | PAK6 | 0.30135015 |
92 | AKT2 | 0.29972742 |
93 | LATS1 | 0.28358232 |
94 | SGK494 | 0.27948184 |
95 | SGK223 | 0.27948184 |
96 | RPS6KA1 | 0.25532674 |
97 | CASK | 0.24073748 |
98 | PRKG2 | 0.23727839 |
99 | PTK6 | 0.23413481 |
100 | PRKCH | 0.22349019 |
101 | PRKCQ | 0.21657470 |
102 | JAK1 | 0.21000510 |
103 | LRRK2 | 0.18991779 |
104 | UHMK1 | 0.17719374 |
105 | ADRBK1 | 0.17241666 |
106 | MARK3 | 0.16992009 |
107 | PRKCA | 0.16636285 |
108 | BMPR1B | 0.16252509 |
109 | PRKD3 | 0.15960333 |
110 | DAPK2 | 0.15139144 |
111 | PRKG1 | 0.15054508 |
112 | FER | 0.14697419 |
113 | SGK1 | 0.14372272 |
114 | PRKCB | 0.12923567 |
115 | CAMK2B | 0.12321561 |
116 | MAP3K4 | 0.10872824 |
117 | EPHB1 | 0.09919471 |
118 | MAPK7 | 0.09747089 |
119 | PDGFRB | 0.09607807 |
120 | RPS6KA3 | 0.09509176 |
121 | ICK | 0.08497182 |
122 | SGK3 | 0.08035329 |
123 | MAP2K4 | 0.07673383 |
124 | MAPK11 | 0.07252650 |
125 | MTOR | 0.06821503 |
126 | SIK1 | 0.05100571 |
127 | JAK2 | 0.04995491 |
128 | EPHB2 | 0.04126268 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 6.29050385 |
2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.12858466 |
3 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.08039081 |
4 | Parkinsons disease_Homo sapiens_hsa05012 | 3.74736306 |
5 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.72052105 |
6 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.58355829 |
7 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.36532428 |
8 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.20494817 |
9 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.14686059 |
10 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.98722560 |
11 | Alzheimers disease_Homo sapiens_hsa05010 | 2.76566757 |
12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.67327715 |
13 | Carbon metabolism_Homo sapiens_hsa01200 | 2.52790240 |
14 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.49689965 |
15 | Huntingtons disease_Homo sapiens_hsa05016 | 2.40428697 |
16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.37095421 |
17 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.24934154 |
18 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.92430527 |
19 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.67828725 |
20 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.60726936 |
21 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.54696572 |
22 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.52038767 |
23 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.47058613 |
24 | Viral myocarditis_Homo sapiens_hsa05416 | 1.45246306 |
25 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.22460028 |
26 | Morphine addiction_Homo sapiens_hsa05032 | 1.08834479 |
27 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.02047116 |
28 | GABAergic synapse_Homo sapiens_hsa04727 | 1.00517706 |
29 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.98074732 |
30 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.97229541 |
31 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.95093277 |
32 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.93028967 |
33 | Insulin resistance_Homo sapiens_hsa04931 | 0.90033394 |
34 | Cocaine addiction_Homo sapiens_hsa05030 | 0.88560214 |
35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.88109247 |
36 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.83833562 |
37 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.82860346 |
38 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.82740747 |
39 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.79164167 |
40 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.79062819 |
41 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.75917208 |
42 | Salivary secretion_Homo sapiens_hsa04970 | 0.72179820 |
43 | Peroxisome_Homo sapiens_hsa04146 | 0.71438266 |
44 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.68668683 |
45 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.68654638 |
46 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.66958894 |
47 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.66466877 |
48 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.65883300 |
49 | Lysine degradation_Homo sapiens_hsa00310 | 0.65253405 |
50 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.65214084 |
51 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.61494656 |
52 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.60883426 |
53 | Focal adhesion_Homo sapiens_hsa04510 | 0.55433449 |
54 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.54927278 |
55 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.54350122 |
56 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.52272782 |
57 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.51272451 |
58 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.48655049 |
59 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.48518255 |
60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.46706342 |
61 | Long-term potentiation_Homo sapiens_hsa04720 | 0.45098240 |
62 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.41526795 |
63 | Galactose metabolism_Homo sapiens_hsa00052 | 0.40651371 |
64 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.40647897 |
65 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.40513514 |
66 | Nicotine addiction_Homo sapiens_hsa05033 | 0.39644278 |
67 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.39500740 |
68 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.38657007 |
69 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.37292518 |
70 | Mineral absorption_Homo sapiens_hsa04978 | 0.37153131 |
71 | Melanogenesis_Homo sapiens_hsa04916 | 0.36935574 |
72 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.36619951 |
73 | Renin secretion_Homo sapiens_hsa04924 | 0.35828392 |
74 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.35424259 |
75 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.34747659 |
76 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.34402698 |
77 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.33827897 |
78 | Metabolic pathways_Homo sapiens_hsa01100 | 0.33309256 |
79 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.32612037 |
80 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.32362963 |
81 | Sulfur relay system_Homo sapiens_hsa04122 | 0.29929441 |
82 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.28407685 |
83 | Tight junction_Homo sapiens_hsa04530 | 0.28206867 |
84 | Insulin secretion_Homo sapiens_hsa04911 | 0.27975658 |
85 | Circadian entrainment_Homo sapiens_hsa04713 | 0.23393143 |
86 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.23256553 |
87 | Adherens junction_Homo sapiens_hsa04520 | 0.21134148 |
88 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.20721328 |
89 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.18629583 |
90 | ABC transporters_Homo sapiens_hsa02010 | 0.17802316 |
91 | Phototransduction_Homo sapiens_hsa04744 | 0.17573866 |
92 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.17182464 |
93 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.16997298 |
94 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.15929774 |
95 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.15910453 |
96 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.14883310 |
97 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.13774193 |
98 | Amoebiasis_Homo sapiens_hsa05146 | 0.13320492 |
99 | Circadian rhythm_Homo sapiens_hsa04710 | 0.12305701 |
100 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.11333149 |
101 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.10616224 |
102 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.10487341 |
103 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.09727560 |
104 | Platelet activation_Homo sapiens_hsa04611 | 0.09286258 |
105 | Olfactory transduction_Homo sapiens_hsa04740 | 0.08659184 |
106 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.08489283 |
107 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.08237279 |
108 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.08225656 |
109 | Gap junction_Homo sapiens_hsa04540 | 0.07592103 |
110 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.07234767 |
111 | Taste transduction_Homo sapiens_hsa04742 | 0.05462325 |
112 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.04917445 |
113 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.03569209 |
114 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.02724737 |
115 | Bile secretion_Homo sapiens_hsa04976 | 0.00488502 |
116 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.00206238 |
117 | Toxoplasmosis_Homo sapiens_hsa05145 | -1.1193865 |
118 | Glycerolipid metabolism_Homo sapiens_hsa00561 | -0.0333282 |
119 | FoxO signaling pathway_Homo sapiens_hsa04068 | -0.0324942 |
120 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | -0.0321313 |
121 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | -0.0290128 |
122 | VEGF signaling pathway_Homo sapiens_hsa04370 | -0.0090798 |
123 | Small cell lung cancer_Homo sapiens_hsa05222 | -0.0030579 |
124 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | -0.0026689 |